Page 111 - MI-2-2
P. 111

Microbes & Immunity                                               Big data and DNN-based DTI model in CHP



            19.  Chang S, Wang LH, Chen BS. Investigating core signaling   30.  Kumar S, Boehm J, Lee JC. p38 MAP kinases: Key signalling
               pathways of hepatitis B virus pathogenesis for biomarkers   molecules as therapeutic targets for inflammatory diseases.
               identification and drug discovery via systems biology and   Nat Rev Drug Discov. 2003;2(9):717-726.
               deep learning method. Biomedicines. 2020;8(9):320.
                                                                  doi: 10.1038/nrd1177
               doi: 10.3390/biomedicines8090320
                                                               31.  Cuenda  A,  Rousseau  S. p38  MAP-kinases  pathway
            20.  Sakamoto Y, Ishiguro M, Kitagawa G. Akaike Information   regulation, function and role in human diseases.  Biochim
               Criterion Statistics. Vol.  81. Dordrecht, The Netherlands:   Biophys Acta. 2007;1773(8):1358-1375.
               D Reidel. 1986. p. 26853.
                                                                  doi: 10.1016/j.bbamcr.2007.03.010
            21.  UniProt Consortium. UniProt: A worldwide hub of protein
               knowledge. Nucleic Acids Res. 2019;47(D1):D506-D515.  32.  Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF.
                                                                  Abnormal B lymphocyte development, activation, and
               doi: 10.1093/nar/gky1049                           differentiation in mice that lack or overexpress the CD19
            22.  Knox C, Law V, Jewison T,  et al. DrugBank 3.0:   signal transduction molecule. Immunity. 1995;3(1):39-50.
               A  comprehensive  resource  for  ‘omics’  research  on  drugs.      doi: 10.1016/1074-7613(95)90157-4
               Nucleic Acids Res. 2011;39:D1035-D1041.
                                                               33.  Hers I, Vincent EE, Tavaré JM. Akt signalling in health and
               doi: 10.1093/nar/gkq1126                           disease. Cell Signal. 2011;23(10):1515-1527.
            23.  Kim S, Thiessen PA, Bolton EE,  et al. PubChem      doi: 10.1016/j.cellsig.2011.05.004
               substance  and  compound  databases.  Nucleic Acids Res.
               2016;44(D1):D1202-D1213.                        34.  Morley SJ, Naegele S. Phosphorylation of eukaryotic
                                                                  initiation factor (eIF) 4E is not required for de novo protein
               doi: 10.1093/nar/gkv951                            synthesis following recovery from hypertonic stress in
            24.  Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK. BindingDB:   human kidney cells.  J  Biol Chem. 2002;277(36):32855-
               A  web-accessible database of experimentally determined   32859.
               protein-ligand binding  affinities.  Nucleic Acids Res.      doi: 10.1074/jbc.C200376200
               2007;35:D198-D201.
                                                               35.  Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling
               doi: 10.1093/nar/gkl999                            pathways in cancer. Oncogene. 2007;26(22):3279-3290.
            25.  Ting CT, Chen BS. Repurposing multiple-molecule drugs for      doi: 10.1038/sj.onc.1210421
               COVID-19-associated acute respiratory distress syndrome
               and non-viral acute respiratory distress syndrome via a   36.  Liu Y. Renal fibrosis: New insights into the pathogenesis and
               systems biology approach and a DNN-DTI model based on   therapeutics. Kidney Int. 2006;69(2):213-217.
               five drug design specifications. Int J Mol Sci. 2022;23(7):3649.     doi: 10.1038/sj.ki.5000054
               doi: 10.3390/ijms23073649                       37.  Jaffe AB, Hall A. Rho GTPases in transformation and
            26.  Subramanian A, Narayan R, Corsello SM,  et al. A  next   metastasis. Adv Cancer Res. 2002;84:57-80.
               generation connectivity map: L1000 platform and the first      doi: 10.1016/s0065-230x(02)84003-9
               1,000,000 profiles. Cell. 2017;171(6):1437-1452.e17.
                                                               38.  Chien Y, White MA. RAL GTPases are linchpin modulators
               doi: 10.1016/j.cell.2017.10.049                    of human tumour-cell proliferation and survival.  EMBO
            27.  Xiong G, Wu Z, Yi J, et al. ADMETlab 2.0: An integrated   Rep. 2003;4(8):800-806.
               online platform for accurate and comprehensive      doi: 10.1038/sj.embor.embor899
               predictions of ADMET properties.  Nucleic Acids Res.
               2021;49(W1):W5-W14.                             39.  Johnson GL, Lapadat R. Mitogen-activated protein kinase
                                                                  pathways mediated by ERK, JNK, and p38 protein kinases.
               doi: 10.1093/nar/gkab255
                                                                  Science. 2002;298(5600):1911-1912.
            28.  Kyriakis JM, Avruch J. Mammalian MAPK signal      doi: 10.1126/science.1072682
               transduction pathways activated by stress and inflammation:
               A 10-year update. Physiol Rev. 2012;92(2):689-737.  40.  Duronio V. The life of a cell: Apoptosis regulation by the
                                                                  PI3K/PKB pathway. Biochem J. 2008;415(3):333-344.
               doi: 10.1152/physrev.00028.2011
                                                                  doi: 10.1042/bj20081056
            29.  Cowan KN, Heilbut A, Humpl T, Lam C, Ito S,
               Rabinovitch   M. Complete reversal of fatal pulmonary   41.  Wrana JL, Attisano L, Wieser R, Ventura  F, Massagué  J.
               hypertension in rats by a serine elastase inhibitor. Nat Med.   Mechanism of activation of the TGF-beta receptor. Nature.
               2000;6(6):698-702.                                 1994;370(6488):341-347.
               doi: 10.1038/76282                                 doi: 10.1038/370341a0


            Volume 2 Issue 2 (2025)                        103                               doi: 10.36922/mi.4620
   106   107   108   109   110   111   112   113   114   115   116